Valuation: Bayer AG

Market Cap 4.53TCr 5.04TCr 4.18TCr 3.79TCr 7.08TCr 4,80300Cr 7.16TCr 50TCr 20TCr 2,51400Cr 19TCr 19TCr 7,98000Cr P/E 2026 *
19.6x
P/E 2027 * 14.6x
Enterprise Value 7.49TCr 8.35TCr 6.93TCr 6.27TCr 12TCr 7,95300Cr 12TCr 83TCr 33TCr 4,16200Cr 31TCr 31TCr 13,21200Cr EV / Sales 2026 *
1.63x
EV / Sales 2027 * 1.52x
Free-Float
99.99%
Yield 2026 *
0.3%
Yield 2027 * 1.21%
1 day-0.48%
1 week+5.86%
Current month-4.00%
1 month-7.98%
3 months-2.54%
6 months+19.93%
Current year+24.37%
1 week 43.31
Extreme 43.31
46.37
1 month 42.56
Extreme 42.56
50.64
Current year 32.96
Extreme 32.96
53.92
1 year 25.78
Extreme 25.78
53.92
3 years 18.38
Extreme 18.378
53.92
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 60 01/06/2023
Director of Finance/CFO 57 01/06/2026
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 61 01/04/2017
Chairman 68 28/04/2020
Date Insider Type Main position Quantity % Market Cap. Importance
18/03/26 Buy

Director

1,900 0.0002%
18/03/26 Buy

Executive/Senior Manager

13,000 0.0013%
18/03/26 Buy

Director

1,500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-0.26%+5.86%+66.71%+13.63% 5.05TCr
+0.50%+1.38%+57.09%+127.73% 1,14300Cr
+0.86%+5.14%+45.00%+84.34% 65TCr
-0.14%+0.42%+25.69%+101.56% 51TCr
-0.05%+2.28%+49.14%+67.74% 38TCr
-0.63%-5.97%+61.93%+37.25% 35TCr
+0.34%+2.15%+25.26%+54.27% 29TCr
-0.45%+1.19%+2.89%+24.92% 26TCr
+0.87%+3.08%+54.69%+71.67% 24TCr
+0.08%+3.67%+35.05%+104.71% 20TCr
Average +0.19%+1.38%+42.34%+68.78% 40.78TCr
Weighted average by Cap. +0.45%+0.77%+44.04%+86.37%

Financials

2026 *2027 *
Net sales 4.59TCr 5.11TCr 4.24TCr 3.84TCr 7.18TCr 4,86900Cr 7.26TCr 51TCr 20TCr 2,54800Cr 19TCr 19TCr 8,08900Cr 4.71TCr 5.24TCr 4.35TCr 3.94TCr 7.36TCr 4,99500Cr 7.45TCr 52TCr 21TCr 2,61400Cr 20TCr 19TCr 8,29700Cr
Net income 229.69Cr 256.01Cr 212.36Cr 192.33Cr 359.31Cr 24TCr 363.66Cr 2.54TCr 1.01TCr 13TCr 960.69Cr 940.42Cr 41TCr 302.44Cr 337.09Cr 279.62Cr 253.24Cr 473.12Cr 32TCr 478.84Cr 3.34TCr 1.33TCr 17TCr 1.26TCr 1.24TCr 53TCr
Net Debt 2.97TCr 3.31TCr 2.74TCr 2.48TCr 4.64TCr 3,15000Cr 4.7TCr 33TCr 13TCr 1,64800Cr 12TCr 12TCr 5,23300Cr 2.64TCr 2.95TCr 2.44TCr 2.21TCr 4.14TCr 2,80600Cr 4.19TCr 29TCr 12TCr 1,46800Cr 11TCr 11TCr 4,66200Cr
Projected Income Statement - Annual - Bayer AG
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,830
Date Price Change Volume
28/26/28 €46.03 -0.26% 17,87,322
27/26/27 €46.15 +1.29% 18,01,210
26/26/26 €45.56 +3.59% 19,64,992
23/26/23 €43.98 -0.52% 11,83,777
22/26/22 €44.21 -0.94% 16,09,760
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Bayer AG
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
46.15EUR
Average target price
58.22EUR
Spread / Average Target
+26.16%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Bayer AG
  1. Stock Market
  2. Stocks
  3. BAYN Stock